[HTML][HTML] Immunopathogenesis of Behçet's disease and treatment modalities
TB Van der Houwen, PM van Hagen… - Seminars in Arthritis and …, 2022 - Elsevier
Introduction Behçet's disease (BD) is an auto-inflammatory disease, primarily characterized
by recurrent painful mucocutaneous ulcerations. Methods A literature search was performed …
by recurrent painful mucocutaneous ulcerations. Methods A literature search was performed …
Immunopathophysiology and clinical impact of uveitis in inflammatory rheumatic diseases: An update
E Hysa, CA Cutolo, E Gotelli, G Pacini… - European journal of …, 2021 - Wiley Online Library
Background Uveitis is one of the most frequent ophthalmologic manifestations in
rheumatology. Uveal inflammation can underlie a systemic inflammatory rheumatic disease …
rheumatology. Uveal inflammation can underlie a systemic inflammatory rheumatic disease …
LncRNA MEG3 regulates the interplay between Th17 and Treg cells in Behçet's disease and systemic lupus erythematosus
Background Behçet's disease (BD) and systemic lupus erythematosus (SLE) are two
autoimmune inflammatory diseases of indefinite etiology. However, up till now, no study has …
autoimmune inflammatory diseases of indefinite etiology. However, up till now, no study has …
Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease
M Ahmadi, M Yousefi… - Journal of cellular …, 2019 - Wiley Online Library
Impaired inflammatory immune cells have been implicated in the pathogenesis of Behcet's
disease (BD). In the current study, we aimed to evaluate the frequency of T helper (Th) 17 …
disease (BD). In the current study, we aimed to evaluate the frequency of T helper (Th) 17 …
[HTML][HTML] Regulatory T cells in autoimmune vasculitis
Blood vessels are indispensable for host survival and are protected from inappropriate
inflammation by immune privilege. This protection is lost in patients with autoimmune …
inflammation by immune privilege. This protection is lost in patients with autoimmune …
Alemtuzumab as remission induction therapy in Behçet disease: a 20-year experience
AJ Mohammad, RM Smith, YW Chow… - The Journal of …, 2015 - jrheum.org
Objective. To study the efficacy and safety of anti-CD52 antibody (alemtuzumab) in the
treatment of refractory and relapsing Behçet disease (BD). Methods. Thirty-two patients (22 …
treatment of refractory and relapsing Behçet disease (BD). Methods. Thirty-two patients (22 …
[HTML][HTML] Characterization of immune responses associated with ERAP-1 expression in HSV-induced Behçet's disease mouse model
Behçet's disease (BD) is a chronic multisystem inflammatory disorder. Endoplasmic
reticulum aminopeptidase 1 (ERAP1) polymorphism has been reported as a risk factor for …
reticulum aminopeptidase 1 (ERAP1) polymorphism has been reported as a risk factor for …
[HTML][HTML] Finding the Needle in the Haystack: Serological and Urinary Biomarkers in Behçet's Disease: A Systematic Review
M Arbrile, M Radin, D Medica, P Miraglia… - International Journal of …, 2023 - mdpi.com
Urinary and serological markers play an essential role in the diagnostic process of
autoimmune diseases. However, to date, specific and reliable biomarkers for diagnosing …
autoimmune diseases. However, to date, specific and reliable biomarkers for diagnosing …
Th 9 cells in Behçet disease: Possible involvement of IL-9 in pulmonary manifestations
W Kaabachi, M Khaouthar, B Hamdi, I Khalfallah… - Immunology …, 2019 - Elsevier
Behçet disease (BD) is a multisystemic disease some of whose manifestations are
characterized by pulmonary involvements. The purpose of the study was to evaluate the …
characterized by pulmonary involvements. The purpose of the study was to evaluate the …
Regulatory T cells and systemic vasculitis
Regulatory T cells and systemic vasculitis : Current Opinion in Rheumatology Regulatory T
cells and systemic vasculitis : Current Opinion in Rheumatology Log in or Register Subscribe …
cells and systemic vasculitis : Current Opinion in Rheumatology Log in or Register Subscribe …